uPAR is a glycolipid-anchored receptor that brings the serine protease urokinase plasminogen activator to the cell surface to induce peri-cellular proteolysis and engage integrins for cell migration—these activities are opportunities for diagnosis and intervention for cancer treatment. The gene discussed is PLAU; the disease is cancer.